Convatec Group PLC (LON:CTEC – Get Free Report) shot up 0.6% during mid-day trading on Friday. The stock traded as high as GBX 258.60 and last traded at GBX 257.40. Approximately 660,064,688 shares changed hands during mid-day trading, an increase of 1,420% from the average daily volume of 43,435,688 shares. The stock had previously closed at GBX 255.80.
Analysts Set New Price Targets
A number of research analysts recently issued reports on CTEC shares. Berenberg Bank reduced their price target on Convatec Group from GBX 340 to GBX 335 and set a “buy” rating on the stock in a report on Friday, September 11th. Peel Hunt reiterated an “add” rating and issued a GBX 270 price objective on shares of Convatec Group in a report on Tuesday, August 4th. Royal Bank Of Canada reiterated an “outperform” rating and issued a GBX 315 price objective on shares of Convatec Group in a research report on Monday, August 3rd. Deutsche Bank reissued a “buy” rating and set a GBX 315 target price on shares of Convatec Group in a research note on Wednesday, August 5th. Finally, Jefferies Financial Group reissued a “buy” rating and set a GBX 300 target price on shares of Convatec Group in a research note on Wednesday, August 5th. Eight analysts have rated the stock with a Buy rating and one has issued a Hold rating to the company’s stock. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average price target of GBX 305.44.
View Our Latest Report on CTEC
Convatec Group Stock Performance
The company’s 50-day moving average price is GBX 230.34 and its 200 day moving average price is GBX 224.01. The company has a debt-to-equity ratio of 121.83, a quick ratio of 0.96 and a current ratio of 1.93. The stock has a market capitalization of £4.92 billion, a PE ratio of 41.52, a PEG ratio of 0.93 and a beta of 0.77.
Insider Activity
In related news, insider Jens Viebke purchased 24,400 shares of the firm’s stock in a transaction that occurred on Tuesday, October 13th. The stock was bought at an average cost of GBX 230 per share, with a total value of £56,120. 1.00% of the stock is owned by corporate insiders.
Convatec Group Company Profile
ConvaTec Group PLC engages in the development, manufacturing, and sale of medical products, services, and technologies in Europe, North America, and internationally. The company offers advanced wound dressings and skin care products for the management of acute and chronic wounds resulting from various conditions, such as diabetes, and acute conditions resulting from traumatic injury and burns. It also provides ostomy care solutions, including devices, accessories, and services for people with a stoma resulting from colorectal cancer, inflammatory bowel disease, and bladder cancer.
Further Reading
- Five stocks we like better than Convatec Group
- Intuitive Machines’ Business Is Taking Off—Will Its Stock Follow?
- The Next Big Thing May Not Be One Thing: Inside Lazard’s Megatrends ETF
- 3 Power and Grid Stocks That Could Keep Growing Even if AI Spending Slows
- Applied Materials Beats and Raises, But Investors Stay Unconvinced
Receive News & Ratings for Convatec Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Convatec Group and related companies with MarketBeat.com's FREE daily email newsletter.
